<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 21 Aug 2008 09:50:14 BST</pubDate>


	<title>CiteULike: jyuh's Reed</title>
	<description>CiteULike: jyuh's Reed</description>


	<link>http://www.citeulike.org/user/jyuh/author/Reed</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/3129238"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/2840378"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/321648"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/2786137"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/2433571"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/2286651"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/469427"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/1786880"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/1651219"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/jyuh/article/997319"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/jyuh/article/3129238">
    <title>MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.</title>
    <link>http://www.citeulike.org/user/jyuh/article/3129238</link>
    <description>&lt;i&gt;The Journal of clinical investigation, Vol. 116, No. 8. (August 2006), pp. 2262-2271.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;While it is known that monosodium urate (MSU) crystals cause the disease gout, the mechanism by which these crystals stimulate this inflammatory condition has not been clear. Here we find that the Toll/IL-1R (TIR) signal transduction adaptor myeloid differentiation primary response protein 88 (MyD88) is required for acute gouty inflammation. In contrast, other TIR adaptor molecules, TIRAP/Mal, TRIF, and TRAM, are not required for this process. The MyD88-dependent TLR1, -2, -4, -6, -7, -9, and -11 and IL-18 receptor (IL-18R) are not essential for MSU-induced inflammation. Moreover, MSU does not stimulate HEK cells expressing TLR1-11 to activate NF-kappaB. In contrast, mice deficient in the MyD88-dependent IL-1R showed reduced inflammatory responses, similar to those observed in MyD88-deficient mice. Similarly, mice treated with IL-1 neutralizing antibodies also showed reduced MSU-induced inflammation, demonstrating that IL-1 production and IL-1R activation play essential roles in MSU-triggered inflammation. IL-1R deficiency in bone marrow-derived cells did not affect the inflammatory response; however, it was required in non-bone marrow-derived cells. These results indicate that IL-1 is essential for the MSU-induced inflammatory response and that the requirement of MyD88 in this process is primarily through its function as an adaptor molecule in the IL-1R signaling pathway.</description>
    <dc:title>MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals.</dc:title>

    <dc:creator>CJ Chen</dc:creator>
    <dc:creator>Y Shi</dc:creator>
    <dc:creator>A Hearn</dc:creator>
    <dc:creator>K Fitzgerald</dc:creator>
    <dc:creator>D Golenbock</dc:creator>
    <dc:creator>G Reed</dc:creator>
    <dc:creator>S Akira</dc:creator>
    <dc:creator>KL Rock</dc:creator>
    <dc:identifier>doi:10.1172/JCI28075</dc:identifier>
    <dc:source>The Journal of clinical investigation, Vol. 116, No. 8. (August 2006), pp. 2262-2271.</dc:source>
    <dc:date>2008-08-17T00:48:29-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>The Journal of clinical investigation</prism:publicationName>
    <prism:issn>0021-9738</prism:issn>
    <prism:volume>116</prism:volume>
    <prism:number>8</prism:number>
    <prism:startingPage>2262</prism:startingPage>
    <prism:endingPage>2271</prism:endingPage>
    <prism:category>gout</prism:category>
    <prism:category>il1</prism:category>
    <prism:category>msu</prism:category>
    <prism:category>myd88</prism:category>
    <prism:category>tlr</prism:category>
    <prism:category>urate</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/2840378">
    <title>Urinary symptoms in adolescent females: STI or UTI?</title>
    <link>http://www.citeulike.org/user/jyuh/article/2840378</link>
    <description>&lt;i&gt;The Journal of adolescent health : official publication of the Society for Adolescent Medicine, Vol. 40, No. 5. (May 2007), pp. 418-424.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;PURPOSE: To determine if urinary symptoms or urinary tract infections (UTI) were associated with sexually transmitted infections (STI) and which history, clinical, and laboratory findings could distinguish these infections in symptomatic women. METHODS: A cross-sectional sample of 296 sexually active females aged 14-22 years attending a hospital-based teen health center or emergency department were recruited. Genitourinary symptoms, medical and sexual history, and urinalysis results were recorded. STI was defined as a vaginal swab positive for Trichomonas vaginalis or urine nucleic acid amplification test positive for Neisseria gonorrheae or Chlamydia trachomatis. A urine culture with &#62;10,000 colonies of a single pathogen was considered a positive UTI. RESULTS: In the full sample, prevalence of UTI and STI were 17% and 33%, respectively. Neither urinary symptoms nor UTI was significantly associated with STI. Further analyses are reported for the 154 (51%) with urinary symptoms: Positive urine leukocytes, more than one partner in the last three months and history of STI predicted STI. Urinalysis results identified four groups: (1) Normal urinalysis-67% had no infection; (2) Positive nitrites or protein-55% had UTI; (3) Positive leukocytes or blood-62% had STI; and (4) Both nitrites/protein and leukocytes/blood positive-28% had STI and 65% had UTI. Those without a documented UTI were more likely to have trichomoniasis than those with a UTI, and 65% of those with sterile pyuria had STI, mainly trichomoniasis or gonorrhea. CONCLUSIONS: Adolescent females with urinary symptoms should be tested for both UTI and STIs. Urinalysis results may be helpful to direct initial therapy.</description>
    <dc:title>Urinary symptoms in adolescent females: STI or UTI?</dc:title>

    <dc:creator>JS Huppert</dc:creator>
    <dc:creator>F Biro</dc:creator>
    <dc:creator>D Lan</dc:creator>
    <dc:creator>JE Mortensen</dc:creator>
    <dc:creator>J Reed</dc:creator>
    <dc:creator>GB Slap</dc:creator>
    <dc:identifier>doi:10.1016/j.jadohealth.2006.12.010</dc:identifier>
    <dc:source>The Journal of adolescent health : official publication of the Society for Adolescent Medicine, Vol. 40, No. 5. (May 2007), pp. 418-424.</dc:source>
    <dc:date>2008-05-28T08:50:11-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>The Journal of adolescent health : official publication of the Society for Adolescent Medicine</prism:publicationName>
    <prism:issn>1728-0591</prism:issn>
    <prism:volume>40</prism:volume>
    <prism:number>5</prism:number>
    <prism:startingPage>418</prism:startingPage>
    <prism:endingPage>424</prism:endingPage>
    <prism:category>uti</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/321648">
    <title>Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report</title>
    <link>http://www.citeulike.org/user/jyuh/article/321648</link>
    <description>&lt;i&gt;Value in Health, Vol. 8, No. 5. (September 2005), pp. 521-533.&lt;/i&gt;</description>
    <dc:title>Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report</dc:title>

    <dc:creator>Scott Ramsey</dc:creator>
    <dc:creator>Richard Willke</dc:creator>
    <dc:creator>Andrew Briggs</dc:creator>
    <dc:creator>Ruth Brown</dc:creator>
    <dc:creator>Martin Buxton</dc:creator>
    <dc:creator>Anita Chawla</dc:creator>
    <dc:creator>John Cook</dc:creator>
    <dc:creator>Henry Glick</dc:creator>
    <dc:creator>Bengt Liljas</dc:creator>
    <dc:creator>Diana Petitti</dc:creator>
    <dc:creator>Shelby Reed</dc:creator>
    <dc:identifier>doi:10.1111/j.1524-4733.2005.00045.x</dc:identifier>
    <dc:source>Value in Health, Vol. 8, No. 5. (September 2005), pp. 521-533.</dc:source>
    <dc:date>2005-09-15T20:08:23-00:00</dc:date>
    <prism:publicationYear>2005</prism:publicationYear>
    <prism:publicationName>Value in Health</prism:publicationName>
    <prism:issn>1098-3015</prism:issn>
    <prism:volume>8</prism:volume>
    <prism:number>5</prism:number>
    <prism:startingPage>521</prism:startingPage>
    <prism:endingPage>533</prism:endingPage>
    <prism:publisher>Blackwell Publishing</prism:publisher>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/2786137">
    <title>ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.</title>
    <link>http://www.citeulike.org/user/jyuh/article/2786137</link>
    <description>&lt;i&gt;Journal of the American College of Cardiology, Vol. 50, No. 2. (10 July 2007), pp. 187-204.&lt;/i&gt;</description>
    <dc:title>ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.</dc:title>

    <dc:creator>PS Douglas</dc:creator>
    <dc:creator>B Khandheria</dc:creator>
    <dc:creator>RF Stainback</dc:creator>
    <dc:creator>NJ Weissman</dc:creator>
    <dc:creator>RG Brindis</dc:creator>
    <dc:creator>MR Patel</dc:creator>
    <dc:creator>B Khandheria</dc:creator>
    <dc:creator>JS Alpert</dc:creator>
    <dc:creator>D Fitzgerald</dc:creator>
    <dc:creator>P Heidenreich</dc:creator>
    <dc:creator>ET Martin</dc:creator>
    <dc:creator>JV Messer</dc:creator>
    <dc:creator>AB Miller</dc:creator>
    <dc:creator>MH Picard</dc:creator>
    <dc:creator>P Raggi</dc:creator>
    <dc:creator>KD Reed</dc:creator>
    <dc:creator>JS Rumsfeld</dc:creator>
    <dc:creator>AE Steimle</dc:creator>
    <dc:creator>R Tonkovic</dc:creator>
    <dc:creator>K Vijayaraghavan</dc:creator>
    <dc:creator>NJ Weissman</dc:creator>
    <dc:creator>SB Yeon</dc:creator>
    <dc:creator>RG Brindis</dc:creator>
    <dc:creator>PS Douglas</dc:creator>
    <dc:creator>RC Hendel</dc:creator>
    <dc:creator>MR Patel</dc:creator>
    <dc:creator>E Peterson</dc:creator>
    <dc:creator>MJ Wolk</dc:creator>
    <dc:creator>JM Allen</dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:creator></dc:creator>
    <dc:identifier>doi:10.1016/j.jacc.2007.05.003</dc:identifier>
    <dc:source>Journal of the American College of Cardiology, Vol. 50, No. 2. (10 July 2007), pp. 187-204.</dc:source>
    <dc:date>2008-05-12T01:55:10-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Journal of the American College of Cardiology</prism:publicationName>
    <prism:issn>1558-3597</prism:issn>
    <prism:volume>50</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>187</prism:startingPage>
    <prism:endingPage>204</prism:endingPage>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/2433571">
    <title>The ubiquitin-proteasome pathway in cell cycle control.</title>
    <link>http://www.citeulike.org/user/jyuh/article/2433571</link>
    <description>&lt;i&gt;Results Probl Cell Differ, Vol. 42 (2006), pp. 147-181.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Ubiquitin-mediated proteolysis is one of the key mechanisms underlying cell cycle control. The removal of barriers posed by accumulation of negative regulators, as well as the clearance of proteins when they are no longer needed or deleterious, are carried out via the ubiquitin-proteasome system. Ubiquitin conjugating enzymes and protein-ubiquitin ligases collaborate to mark proteins destined for degradation by the proteasome by covalent attachment of multi-ubiquitin chains. Most regulated proteolysis during the cell cycle can be attributed to two families of protein-ubiquitin ligases. The anaphase promoting complex/cyclosome (APC/C) is activated during mitosis and G1 where it is responsible for eliminating proteins that impede mitotic progression and that would have deleterious consequences if allowed to accumulate during G1. SCF (Skp1/Culin/F-box protein) protein-ubiquitin ligases ubiquitylate proteins that are marked by phosphorylation at specific sequences known as phosphodegrons. Targeting of proteins for destruction by phosphorylation provides a mechanism for linking cell cycle regulation to internal and external signaling pathways via regulated protein kinase activities.</description>
    <dc:title>The ubiquitin-proteasome pathway in cell cycle control.</dc:title>

    <dc:creator>SI Reed</dc:creator>
    <dc:source>Results Probl Cell Differ, Vol. 42 (2006), pp. 147-181.</dc:source>
    <dc:date>2008-02-27T05:50:07-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>Results Probl Cell Differ</prism:publicationName>
    <prism:issn>0080-1844</prism:issn>
    <prism:volume>42</prism:volume>
    <prism:startingPage>147</prism:startingPage>
    <prism:endingPage>181</prism:endingPage>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/2286651">
    <title>RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.</title>
    <link>http://www.citeulike.org/user/jyuh/article/2286651</link>
    <description>&lt;i&gt;Gastroenterology, Vol. 133, No. 3. (September 2007), pp. 976-984.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND &#38; AIMS: The retinoblastoma (RB) tumor suppressor is functionally inactivated in most hepatocellular carcinomas (HCC), although the mechanisms by which RB suppresses liver tumorigenesis are poorly defined. We investigated the impact of RB loss on carcinogen-induced liver tumorigenesis. METHODS: Mice harboring liver-specific RB ablation and normal littermates were exposed to the hepatocarcinogen diethylnitrosamine (DEN). The influence of RB loss on liver tumorigenesis was assessed by evaluating tumor multiplicity, proliferation, and genome integrity within tumors arising in RB-deficient and wild-type livers. In silico analyses were used to probe the association between gene expression signatures for RB loss and chromosomal instability and the ability of genes up-regulated by RB loss to predict the survival of human HCC patients. RESULTS: RB deficiency significantly increased tumor multiplicity in livers exposed to DEN. Although hepatocytes in nontumor regions of DEN-exposed livers were quiescent regardless of RB status, tumors arising in RB-deficient livers were significantly more proliferative than those in normal livers and expressed high levels of RB/E2F target genes. Analysis of genes up-regulated by RB loss demonstrated significant overlap with a gene expression signature associated with chromosomal instability. Correspondingly, tumors arising in RB-deficient livers were significantly more likely to harbor hepatocytes exhibiting altered ploidy. Finally, gene expression analysis of human HCCs demonstrated that elevated expression of RB-regulated genes independently predicts poor survival. CONCLUSIONS: RB deletion in the mouse liver enhances DEN-induced tumorigenesis, associated with increased hepatocyte proliferation and compromised genome integrity. Evaluation of RB status may be a useful prognostic factor in human HCC.</description>
    <dc:title>RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.</dc:title>

    <dc:creator>CN Mayhew</dc:creator>
    <dc:creator>SL Carter</dc:creator>
    <dc:creator>SR Fox</dc:creator>
    <dc:creator>CR Sexton</dc:creator>
    <dc:creator>CA Reed</dc:creator>
    <dc:creator>SV Srinivasan</dc:creator>
    <dc:creator>X Liu</dc:creator>
    <dc:creator>K Wikenheiser-Brokamp</dc:creator>
    <dc:creator>GP Boivin</dc:creator>
    <dc:creator>JS Lee</dc:creator>
    <dc:creator>BJ Aronow</dc:creator>
    <dc:creator>SS Thorgeirsson</dc:creator>
    <dc:creator>ES Knudsen</dc:creator>
    <dc:identifier>doi:10.1053/j.gastro.2007.06.025</dc:identifier>
    <dc:source>Gastroenterology, Vol. 133, No. 3. (September 2007), pp. 976-984.</dc:source>
    <dc:date>2008-01-25T02:10:53-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Gastroenterology</prism:publicationName>
    <prism:issn>0016-5085</prism:issn>
    <prism:volume>133</prism:volume>
    <prism:number>3</prism:number>
    <prism:startingPage>976</prism:startingPage>
    <prism:endingPage>984</prism:endingPage>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/469427">
    <title>Towards multidimensional genome annotation</title>
    <link>http://www.citeulike.org/user/jyuh/article/469427</link>
    <description>&lt;i&gt;Nature Reviews Genetics, Vol. 7, No. 2., pp. 130-141.&lt;/i&gt;</description>
    <dc:title>Towards multidimensional genome annotation</dc:title>

    <dc:creator>Jennifer Reed</dc:creator>
    <dc:creator>Iman Famili</dc:creator>
    <dc:creator>Ines Thiele</dc:creator>
    <dc:creator>Bernhard Palsson</dc:creator>
    <dc:identifier>doi:10.1038/nrg1769</dc:identifier>
    <dc:source>Nature Reviews Genetics, Vol. 7, No. 2., pp. 130-141.</dc:source>
    <dc:date>2006-01-18T16:36:02-00:00</dc:date>
    <prism:publicationName>Nature Reviews Genetics</prism:publicationName>
    <prism:issn>1471-0056</prism:issn>
    <prism:volume>7</prism:volume>
    <prism:number>2</prism:number>
    <prism:startingPage>130</prism:startingPage>
    <prism:endingPage>141</prism:endingPage>
    <prism:publisher>Nature Publishing Group</prism:publisher>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/1786880">
    <title>Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients</title>
    <link>http://www.citeulike.org/user/jyuh/article/1786880</link>
    <description>&lt;i&gt;Kidney Int, Vol. 72, No. 9. (2007), pp. 1130-1137.&lt;/i&gt;</description>
    <dc:title>Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients</dc:title>

    <dc:creator>WN Suki</dc:creator>
    <dc:creator>R Zabaneh</dc:creator>
    <dc:creator>JL Cangiano</dc:creator>
    <dc:creator>J Reed</dc:creator>
    <dc:creator>D Fischer</dc:creator>
    <dc:creator>L Garrett</dc:creator>
    <dc:creator>BN Ling</dc:creator>
    <dc:creator>S Chasan-Taber</dc:creator>
    <dc:creator>MA Dillon</dc:creator>
    <dc:creator>AT Blair</dc:creator>
    <dc:creator>SK Burke</dc:creator>
    <dc:identifier>doi:10.1038/sj.ki.5002466</dc:identifier>
    <dc:source>Kidney Int, Vol. 72, No. 9. (2007), pp. 1130-1137.</dc:source>
    <dc:date>2007-10-19T03:30:04-00:00</dc:date>
    <prism:publicationYear>2007</prism:publicationYear>
    <prism:publicationName>Kidney Int</prism:publicationName>
    <prism:volume>72</prism:volume>
    <prism:number>9</prism:number>
    <prism:startingPage>1130</prism:startingPage>
    <prism:endingPage>1137</prism:endingPage>
    <prism:category>ca</prism:category>
    <prism:category>hd</prism:category>
    <prism:category>mortality</prism:category>
    <prism:category>p</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/1651219">
    <title>Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.</title>
    <link>http://www.citeulike.org/user/jyuh/article/1651219</link>
    <description>&lt;i&gt;Kidney Int, Vol. 57, No. 1. (January 2000), pp. 117-128.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis. BACKGROUND: SPARC has been implicated as a counteradhesive and antiproliferative protein associated with deposits of extracellular matrix in renal disease. METHOD: We have examined the effect of recombinant SPARC containing a C-terminal His tag (rSPARC) in an acute model of mesangial cell injury that is induced in the rat by an antibody against the Thy1 antigen on the mesangial cell membrane. The recombinant protein was administered 24 hours after the induction of nephritis and was infused through day 4. RESULTS: rSPARC was localized to the renal glomeruli of rats treated with anti-Thy1 antibody. Type I collagen and fibronectin, as well as transforming growth factor-beta1 (TGF-beta1), were increased at day 5 in rats treated with rSPARC (N = 4, P &#60; 0.05 vs. delivery buffer), but only minimal effects were seen on mesangial cell and endothelial cell proliferation. In primary cultures of rat mesangial cells, infusion of rSPARC was associated with increases in TGF-beta1 mRNA and in total, secreted TGF-beta1 protein. CONCLUSIONS: rSPARC stimulates expression of TGF-beta1 both in vitro and in vivo. Given the closely regulated expression of SPARC, TGF-beta1, and type I collagen in several animal models of glomerulonephritis, we propose that SPARC could be one of the major mediators of the induction of TGF-beta1 in renal disease.</description>
    <dc:title>Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis.</dc:title>

    <dc:creator>JA Bassuk</dc:creator>
    <dc:creator>R Pichler</dc:creator>
    <dc:creator>JD Rothmier</dc:creator>
    <dc:creator>J Pippen</dc:creator>
    <dc:creator>K Gordon</dc:creator>
    <dc:creator>RL Meek</dc:creator>
    <dc:creator>AD Bradshaw</dc:creator>
    <dc:creator>D Lombardi</dc:creator>
    <dc:creator>TP Strandjord</dc:creator>
    <dc:creator>M Reed</dc:creator>
    <dc:creator>EH Sage</dc:creator>
    <dc:creator>WG Couser</dc:creator>
    <dc:creator>R Johnson</dc:creator>
    <dc:identifier>doi:10.1046/j.1523-1755.2000.00811.x</dc:identifier>
    <dc:source>Kidney Int, Vol. 57, No. 1. (January 2000), pp. 117-128.</dc:source>
    <dc:date>2007-09-13T09:22:48-00:00</dc:date>
    <prism:publicationYear>2000</prism:publicationYear>
    <prism:publicationName>Kidney Int</prism:publicationName>
    <prism:issn>0085-2538</prism:issn>
    <prism:volume>57</prism:volume>
    <prism:number>1</prism:number>
    <prism:startingPage>117</prism:startingPage>
    <prism:endingPage>128</prism:endingPage>
    <prism:category>no-tag</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/jyuh/article/997319">
    <title>Statistical analysis of real-time PCR data.</title>
    <link>http://www.citeulike.org/user/jyuh/article/997319</link>
    <description>&lt;i&gt;BMC Bioinformatics, Vol. 7 (2006)&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;BACKGROUND: Even though real-time PCR has been broadly applied in biomedical sciences, data processing procedures for the analysis of quantitative real-time PCR are still lacking; specifically in the realm of appropriate statistical treatment. Confidence interval and statistical significance considerations are not explicit in many of the current data analysis approaches. Based on the standard curve method and other useful data analysis methods, we present and compare four statistical approaches and models for the analysis of real-time PCR data. RESULTS: In the first approach, a multiple regression analysis model was developed to derive DeltaDeltaCt from estimation of interaction of gene and treatment effects. In the second approach, an ANCOVA (analysis of covariance) model was proposed, and the DeltaDeltaCt can be derived from analysis of effects of variables. The other two models involve calculation DeltaCt followed by a two group t-test and non-parametric analogous Wilcoxon test. SAS programs were developed for all four models and data output for analysis of a sample set are presented. In addition, a data quality control model was developed and implemented using SAS. CONCLUSION: Practical statistical solutions with SAS programs were developed for real-time PCR data and a sample dataset was analyzed with the SAS programs. The analysis using the various models and programs yielded similar results. Data quality control and analysis procedures presented here provide statistical elements for the estimation of the relative expression of genes using real-time PCR.</description>
    <dc:title>Statistical analysis of real-time PCR data.</dc:title>

    <dc:creator>JS Yuan</dc:creator>
    <dc:creator>A Reed</dc:creator>
    <dc:creator>F Chen</dc:creator>
    <dc:creator>CN Stewart</dc:creator>
    <dc:identifier>doi:10.1186/1471-2105-7-85</dc:identifier>
    <dc:source>BMC Bioinformatics, Vol. 7 (2006)</dc:source>
    <dc:date>2006-12-15T17:04:35-00:00</dc:date>
    <prism:publicationYear>2006</prism:publicationYear>
    <prism:publicationName>BMC Bioinformatics</prism:publicationName>
    <prism:issn>1471-2105</prism:issn>
    <prism:volume>7</prism:volume>
    <prism:category>pcr</prism:category>
    <prism:category>statistics</prism:category>
</item>



</rdf:RDF>

